{"product_id":"global-cellular-and-gene-therapy-cdmo-market-growth-status-and-outlook-2023-2029","title":"Global Cellular and Gene Therapy CDMO Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Cellular and Gene Therapy CDMO Market Growth (Status and Outlook) 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “Cellular and Gene Therapy CDMO Industry Forecast” looks at past sales and reviews total world Cellular and Gene Therapy CDMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Cellular and Gene Therapy CDMO sales for 2023 through 2029. With Cellular and Gene Therapy CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cellular and Gene Therapy CDMO industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Cellular and Gene Therapy CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Cellular and Gene Therapy CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cellular and Gene Therapy CDMO market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cellular and Gene Therapy CDMO and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cellular and Gene Therapy CDMO.\u003c\/p\u003e\n\n\u003cp\u003eThe global Cellular and Gene Therapy CDMO market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eUnited States market for Cellular and Gene Therapy CDMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eChina market for Cellular and Gene Therapy CDMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eEurope market for Cellular and Gene Therapy CDMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eGlobal key Cellular and Gene Therapy CDMO players cover Catalent, Lonza, Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec and Pharmaron, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Cellular and Gene Therapy CDMO market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003cbr\u003e\nCell Therapy\u003cbr\u003e\nViral Vectors\u003cbr\u003e\nPlasmid\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003cbr\u003e\nCommercial\u003cbr\u003e\nAcademic Research\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003cbr\u003e\nAmericas\u003cbr\u003e\n United States\u003cbr\u003e\n Canada\u003cbr\u003e\n Mexico\u003cbr\u003e\n Brazil\u003cbr\u003e\nAPAC\u003cbr\u003e\n China\u003cbr\u003e\n Japan\u003cbr\u003e\n Korea\u003cbr\u003e\n Southeast Asia\u003cbr\u003e\n India\u003cbr\u003e\n Australia\u003cbr\u003e\nEurope\u003cbr\u003e\n Germany\u003cbr\u003e\n France\u003cbr\u003e\n UK\u003cbr\u003e\n Italy\u003cbr\u003e\n Russia\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003cbr\u003e\n Egypt\u003cbr\u003e\n South Africa\u003cbr\u003e\n Israel\u003cbr\u003e\n Turkey\u003cbr\u003e\n GCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\nCatalent\u003cbr\u003e\nLonza\u003cbr\u003e\nCharles River\u003cbr\u003e\nThe Discovery Labs\u003cbr\u003e\nBIOCENTRIQ\u003cbr\u003e\nFUJIFILM Diosynth Biotechnologies\u003cbr\u003e\nExothera\u003cbr\u003e\nWuXi AppTec\u003cbr\u003e\nPharmaron\u003cbr\u003e\nOBiO\u003cbr\u003e\nCell Therapies\u003cbr\u003e\nAGC Biologics\u003cbr\u003e\nCytiva\u003cbr\u003e\nHelixmith\u003cbr\u003e\nThermoGenesis\u003cbr\u003e\nAnemocyte\u003cbr\u003e\nThermo Fisher Scientific\u003cbr\u003e\nCBM\u003cbr\u003e\nBio Elpida\u003cbr\u003e\nGenezen\u003cbr\u003e\nCCRM\u003cbr\u003e\nRoslinCT\u003cbr\u003e\nGenScript ProBio\u003cbr\u003e\nOxford BioMedica\u003cbr\u003e\nPorton Pharma Solutions\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ 120 Pages \/ MCW16227789","offer_id":47646786224434,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-cellular-and-gene-therapy-cdmo-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}